Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab...
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
About this item
Full title
Author / Creator
Tessoulin, Benoit , Chiron, David , Thieblemont, Catherine , Oberic, Lucie , Bouadballah, Kamal , Gyan, Emmanuel , Damaj, Gandhi , Ribrag, Vincent , Gressin, Rémy , Feugier, Pierre , Casasnovas, Olivier , Zerazhi, Hacène , Lemonnier, François , Maisonneuve, Hervé , Joubert, Clementine , Van Den Neste, Eric , Lamy, Thierry , Tilly, Hervé , Moreau, Anne , Hermine, Olivier and Le Gouill, Steven
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
LyMA trial has demonstrated the benefit of rituximab maintenance after autologous stem cell transplantation (ASCT) in previously untreated mantle-cell lymphoma patients (MCL). Induction consisted of four courses of R-DHAP (rituximab, dexamethasone, high-dose cytarabine, and platinum derivative). The platinum derivative (PD) choice was free: R-DHA-c...
Alternative Titles
Full title
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
Authors, Artists and Contributors
Author / Creator
Chiron, David
Thieblemont, Catherine
Oberic, Lucie
Bouadballah, Kamal
Gyan, Emmanuel
Damaj, Gandhi
Ribrag, Vincent
Gressin, Rémy
Feugier, Pierre
Casasnovas, Olivier
Zerazhi, Hacène
Lemonnier, François
Maisonneuve, Hervé
Joubert, Clementine
Van Den Neste, Eric
Lamy, Thierry
Tilly, Hervé
Moreau, Anne
Hermine, Olivier
Le Gouill, Steven
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03203334v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03203334v1
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/s41409-020-01198-2
